← Every firm

Camber Pharmaceuticals Inc. FDA Recalls

2 recalls on file across drugs, 1 of them Class I and 1 still open. This firm is not matched to a listed company.

Newest first

Class I is the FDA's most serious grade: a reasonable probability of serious harm or death.

Product
Atovaquone Oral Suspension USP, 750 mg/5 mL, Packaged in 210 mL bottle, Manufactured for: Camber Pharmaceuticals, Inc., Class IMar 13, 2023Microbial Contamination of Non-Sterile Product: Objectionabl
Lacosamide Oral Solution, USP, CV, 10mg/mL, packaged in 200 mL bottle, Rx Only, Manufactured for: Camber PharmaceuticalsClass IIIDec 6, 2022Failed Excipient Specifications: out of specification result

Related datasets